L-canavanine as a radiosensitization agent for human pancreatic cancer cells

Molecular and Cellular Biochemistry

Volumn 244, Issue 1-2, 2003, Pages 37-43

  Bence, Aimee K ^a   Adams, Val R ^a   Crooks, Peter A ^a  

^a University of Kentucky   (United States)

Author keywords

Cell cycle analysis; Ionizing radiation; L canavanine; Median effect analysis; Pancreatic cancer; Radiosensitization

Indexed keywords

CANAVANINE; RADIOSENSITIZING AGENT;

CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; PANCREAS CANCER; PANCREAS CELL; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

CANAVANINE; CELL CYCLE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; MODELS, CHEMICAL; PANCREATIC NEOPLASMS; RADIATION, IONIZING; RADIATION-SENSITIZING AGENTS; TIME FACTORS;

AGOUTI PACA;

EID: 0037306494     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022435202066     Document Type: Review

References (41)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M: Cancer statistics, 2001. CA Cancer J Clin 51: 15-39, 2001
2. Warshaw AL, Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med 326: 455-465, 1992
3. Rosenthal GA: The biological effects and mode of action of L-canavanine, a structural analogue of L-arginine. Q Rev Biol 52: 155-178, 1977
4. Thomas DA, Rosenthal GA, Gold DV, Dickey K: Growth inhibition of a rat colon tumor by L-canavanine. Cancer Res 46: 2898-2903, 1986
5. Green MH, Brooks TL, Mendelsohn J, Howell SB: Antitumor activity of L-canavanine against L1210 murine leukemia. Cancer Res 40: 535-537, 1980
6. Naha PM: An experimental model for selective inhibition of proliferating cells by chemotherapeutic agents. Cell Biol Int Rep 4: 829-839, 1980
7. Naha PM, Silcock JM, Fellows L: Reappraisal of L-canavanine as an anti-tumour agent. Cell Biol Int Rep 4: 155-166, 1980
8. Crooks PA, Rosenthal GA: Use of L-canavanine as a therapeutic agent for the treatment of pancreatic cancer. U.S. Patent 5,552,440. September 3, 1996
9. Thomas DA, Rosenthal GA: Toxicity and pharmacokinetics of the non-protein amino acid L-canavanine in the rat. Toxicol Appl Pharmacol 91: 395-405, 1987
10. Rosenthal GA, Dahlman DL: L-Canavanine and protein synthesis in the tobacco hornworm Manduca sexta. Proc Natl Acad Sci USA 83: 14-18, 1986
11. Rosenthal GA, Lambert J, Hoffmann D: Canavanine incorporation into the antibacterial proteins of the fly, Phormia terranovae (Diptera), and its effect on biological activity. J Biol Chem 264: 9768-9771, 1989
12. Rosenthal GA, Reichhart JM, Hoffmann JA: L-Canavanine incorporation into vitellogenin and macromolecular conformation. J Biol Chem 264: 13693-13696, 1989
13. Mattei E, Damasi D, Mileo AM, Delpino A, Ferrini U: Stress response, survival and enhancement of heat sensitivity in a human melanoma cell line treated with L-canavanine. Anticancer Res 12: 757-762, 1992
14. Laszlo A, Li GC: Effect of amino acid analogs on the development of thermotolerance and on thermotolerant cells. J Cell Physiol 154: 419-432, 1993
15. Ackerman WW, Cox DC, Dinka S: Control of histones and DNA synthesis with canavanine, puromycin, and polio virus. Biochem Biophys Res Commun 19: 745-750, 1965
16. Hare JD: Reversible inhibition of DNA synthesis by the arginine analog canavanine in hamster and mouse cells in vitro. Exptl Cell Res 58: 170-174, 1969
17. Schactele CF, Rogers P: Canavanine death in Escherichia coli. J Mol Biol 34: 474-489, 1965
18. Amorino GP, Freeman ML, Choy H: Enhancement of radiation effects in vitro by the estrogen metabolite 2-methoxyestradiol. Radiat Res 153: 384-391, 2000
19. Buolamwini JK: Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des 6: 379-392, 2000
20. Choy H, Rodriguez FF, Koester S, Hilsenbeck S, Von Hoff DD: Investigation of taxol as a potential radiation sensitizer. Cancer 71: 3774-3778, 1993
21. Bodner WR, Hilaris BS, Mastoras DA: Radiation therapy in pancreatic cancer: Current practice and future trends. J Clin Gastroenterol 30: 230-233, 2000
22. Green MH, Ward JF: Enhancement of human tumor cell killing by L-canavanine in combination with γ-radiation. Cancer Res 40: 4180-4182, 1983
23. Rosenthal GA: Preparation and colorimetric analysis of L-canavanine. Anal Biochem 77: 147-151, 1977
24. Rosenthal GA: The preparation and colorimetric analysis of L-canaline. Anal Biochem 51: 354-361, 1973
25. Bence AK, Crooks PA: Synthesis of L-indospicine. Syn Commun 32: 2075-2082, 2002
26. Cory AH, Owen TC, Barltrop JA, Cory JG: Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3: 207-212, 1991
27. Chou TC: Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. J Theor Biol 59: 253-276, 1976
28. Chou TC, Talalay P: Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55, 1984
29. Merlin JL: Concepts of synergism and antagonism. Anticancer Res 14: 2315-2319, 1994
30. Ding Y, Matsukawa Y, Ohtani Fujita N, Kato D, Dao S, Fujii T, Naito Y, Yoshikawa T, Sakai T, Rosenthal GA: Growth inhibition of A549 human lung adenocarcinoma cells by L-canavanine is associated with p21/WAF1 induction. Jpn J Cancer Res 90: 69-74, 1999
31. Gu Y, Turck CW, Morgan DO: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710, 1993
32. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, Kern SE: p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 54: 3025-3033, 1994
33. Bouvet M, Bold RJ, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Chandra J, Chada S, Fang B, Roth JA: Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer. Ann Surg Oncol 5: 681-688, 1998
34. Mogaki M, Hirota M, Chaney WG, Pour PM: Comparison of p53 protein expression and cellular localization in human and hamster pancreatic cancer cell lines. Carcinogenesis 14: 2589-2594, 1993
35. Wang SR, Su HL, Chiu CC, Huang MH, Tsai CY, Tsai JJ, Yu CL: Alteration of intracellular DNA and RNA patterns by liver arginase studied with flow cytometry. Chung Hua I Hsueh Tsa Chih (Taipei) 50: 267-272, 1992
36. Schmidlin A, Wiesinger H: Transport of L-arginine in cultured glial cells. Glia 11: 262-268, 1994
37. Rosenthal GA, Harper L: L-Homoarginine studies provide insight into the antimetabolic properties of L-canavanine. Insect Biochem Mol Biol 26: 389-394, 1996
38. Swaffar DS, Ang CY: Growth inhibitory effect of L-canavanine against MIA PaCa-2 pancreatic cancer cells is not due to conversion to its toxic metabolite canaline. Anticancer Drugs 10: 113-118, 1999
39. Terasima T, Tolmach LJ: X-ray sensitivity and DNA synthesis in synchronous populations of HeLa Cells. Science 140: 490-492, 1963
40. Sinclair WK, Morton RA: X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat Res 29: 450-474, 1966
41. Brown KD, Lataxes TA, Shangary S, Mannino JL, Giardina JF, Chen J, Baskaran R: Ionizing radiation exposure results in up-regulation of Ku70 via a p53/ataxia-telangiectasia-mutated protein-dependent mechanism. J Biol Chem 275: 6651-6656, 2000